Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Debt to Equity (2016 - 2020)

Cardiff Oncology (CRDF) has disclosed Debt to Equity for 7 consecutive years, with $0.01 as the latest value for Q2 2020.

  • Quarterly Debt to Equity changed N/A to $0.01 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $0.01 through Jun 2020, changed N/A year-over-year, with the annual reading at $0.2 for FY2017, 75.53% down from the prior year.
  • Debt to Equity hit $0.01 in Q2 2020 for Cardiff Oncology, down from $0.25 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.55 in Q1 2017 to a low of $0.01 in Q2 2020.
  • Historically, Debt to Equity has averaged $0.52 across 4 years, with a median of $0.43 in 2016.
  • Biggest five-year swings in Debt to Equity: surged 293.69% in 2017 and later crashed 83.82% in 2018.
  • Year by year, Debt to Equity stood at $0.84 in 2016, then tumbled by 75.53% to $0.2 in 2017, then rose by 22.7% to $0.25 in 2018, then tumbled by 96.17% to $0.01 in 2020.
  • Business Quant data shows Debt to Equity for CRDF at $0.01 in Q2 2020, $0.25 in Q1 2018, and $0.2 in Q4 2017.